Navigation Links
CSHL scientists discover how a tumor suppressor induces senescence and staves off cancer
Date:4/13/2010

Cold Spring Harbor, N.Y. A frequently mutated gene in human cancers is the reitnoblastoma (RB) gene, which controls a potent tumor suppression pathway. Mutations in the gene disable the vast and intricate RB pathway in virtually all tumor cells, leading to disturbances in a host of cellular functions and ultimately provoking cancer. But which of these functions is crucial for the gene's tumor-suppressing activity has been uncertain.

"We have now found that a key function of RB in suppressing cancer stems from its ability to induce cellular senescence, a stage of growth arrest in which cells no longer divide," explains Cold Spring Harbor Laboratory (CSHL) Professor and HHMI investigator Scott Lowe, Ph.D. His team's findings appear online on 13th April in the journal Cancer Cell.

RB's exact mode of activity has been difficult to tease out because it is part of a multigene family that includes two other members that are structurally very similar to RB and have highly overlapping functions. And yet, RB's activities appear to be a more vital part of cells' anti-cancer arsenal as compared to other RB family members, which are very rarely mutated in human cancers.

One of the cellular processes controlled by the RB family is cellular senescence, which is now known to act as a barrier against cancer. "So we hypothesized that the RB protein must exclusively target and control certain senescence-related proteins, which in turn must mediate its potent tumor- suppressive function," explains Lowe.

To investigate the relative effects of each RB family member on senescence, Lowe's team generated multiple short hairpin RNA (shRNA) molecules that specifically shut off individual RB family genes when introduced into human cells with intact RB networks. The team then switched on an oncogene in these cells, which normally triggers cells to cease dividing and enter the senescence mode as part of a failsafe mechanism that prevents cancer.

The team found that when RB alone was switched off, the cells could not efficiently undergo this process of oncogene-induced senescence. When these cells lost RB activity, they could not shut off DNA replication, began to replicate out of control and developed genomic instability. "These aberrant processes, when exacerbated by breakdowns in other control mechanisms, lead to the development of malignant tumors," says Agustin Chicas, Ph.D., a postdoctoral fellow working with Dr. Lowe and the lead investigator in the study.

Further investigations showed that a key target of RB is a gene called cyclin E1, which has been found to be overactive in many human tumors and is often associated with poor prognosis in patients. Its normal function is to spur DNA replication during the cell cycle and hence it is tightly suppressed by RB in senescent cells. The team showed that the loss of RB frees cyclin E1, thus allowing cells to escape senescence.

"Our team's findings suggest that the selective targeting of DNA replication genes during senescence represents one key activity of RB in tumor suppression," says Lowe.


'/>"/>

Contact: Hema Bashyam
bashyam@cshl.edu
516-367-6822
Cold Spring Harbor Laboratory
Source:Eurekalert

Related medicine news :

1. Scientists ID a protein that splices and dices genes
2. Breakthrough by Danish scientists in preventing maternal malaria
3. NIH scientists identify maternal and fetal genes that increase preterm birth risk
4. UM School of Medicine scientists find new malaria vaccine is safe and protective in children
5. Gladstone scientists identify target that may reduce complications of obesity
6. Scientists map out regulatory regions of genome, hot spots for diabetes genes
7. Doctors and Scientists Create New Society to Promote Non-Animal Toxicology Testing Methods
8. Scientists discover enzyme that cleans cancer cells
9. Scientists Decode Brain Cancer Cell Line
10. Scientists show how molecular switch helps pancreatic cancer beat drugs
11. Brain scientists extend map of fear memory formation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... Battle Creek, Michigan (PRWEB) , ... June 26, 2016 , ... ... abuse, joined as sponsor of the 2016 Cereal Festival and World’s Longest Breakfast Table ... held in honor of the city’s history as home to some of the world’s ...
(Date:6/26/2016)... Carolina (PRWEB) , ... June 26, 2016 , ... ... of a new product that was developed to enhance the health of felines. The ... centuries. , The two main herbs in the PawPaws Cat Kidney Support ...
(Date:6/26/2016)... ... June 26, 2016 , ... ... they have been diagnosed with endometriosis. These women need a treatment plan to ... a comprehensive approach that can help for preservation of fertility and ultimately achieving ...
(Date:6/25/2016)... , ... June 25, 2016 , ... Austin residents seeking ... American College of Mohs Surgery and to Dr. Russell Peckham for medical and surgical ... effective treatment for skin cancer. The selective fellowship in Mohs Micrographic Surgery completed by ...
(Date:6/25/2016)... Viejo, California (PRWEB) , ... June 25, 2016 , ... ... to fit their specific project," said Christina Austin - CEO of Pixel Film Studios. ... fully customizable and all within Final Cut Pro X . Simply select a ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)... OTTAWA, Ontario , June 27, 2016  VMS ... the Company,s Board will take whatever measures required to ... the Company,s stock which is currently listed on the ... S Wexler, Company Chairman and CEO, "We are seeing ... be difficult to understand, not only by the Company, ...
(Date:6/24/2016)... , June 24, 2016  Global Blood ... biopharmaceutical company developing novel therapeutics for the treatment ... today announced the closing of its previously announced ... stock, at the public offering price of $18.75 ... offering were offered by GBT. GBT estimates net ...
(Date:6/24/2016)... The Academy of Managed Care Pharmacy (AMCP) ... would allow biopharmaceutical companies to more easily share health ... and coverage decisions, a move that addresses the growing ... The recommendations address restrictions in the sharing of ... label, a prohibition that hinders decision makers from accessing ...
Breaking Medicine Technology: